Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska Native, and non-Native American children aged < 2 years
Km. Miernyk et al., Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska Native, and non-Native American children aged < 2 years, CLIN INF D, 31(1), 2000, pp. 34-41
High rates of invasive pneumococcal disease have been described among infan
ts living in various Native American communities. In this study, we evaluat
ed the immunogenicity of a 7-valent pneumococcal vaccine consisting of sero
types 4, 6B, 9V, 14, 18C, 19F, and 23F covalently linked to the outer membr
ane protein complex of Neisseria meningitidis in Apache and Navajo Indian,
Alaska Native, and non-Native American children. The vaccine was administer
ed at ages 2, 4, and 6 months; a booster dose was given at age 15 months. L
evels of serotype-specific immunoglobulin G (IgG) were measured by a standa
rdized enzyme-linked immunosorbent assay. The responses after 3 primary dos
es of vaccine were similar in all 3 groups of children, except for those to
serotypes 14 and 23F One month after the booster dose, geometric mean conc
entrations (GMCs) of serotype-specific Ige antibodies increased significant
ly in all 3 groups of children, compared with GMCs of IgG antibodies to pne
umococcal serotypes before the booster dose.